Published on in CHOP News
A leading study site for nearly a decade, CHOP will be part of a network of treatment centers in the country offering the therapy to patients who require regular blood transfusions.
Published on in CHOP News
CHOP researchers have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells.
Published on in CHOP News
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.
Published on in CHOP News, Cardiac Center Provider Updates
CHOP researchers have identified two transcription factors that are involved in silencing fetal hemoglobin in adult red blood cells.
Published on in CHOP News
Prestigious award recognizes Dr. High’s contribution to improving children’s health through her gene therapy research, which began during her time at CHOP.
Published on in CHOP News
In a COG trial, CHOP researchers found adding bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL).
Published on in CHOP News
CHOP researchers found that levels of proteins in the plasma of patients with MIS-C are significantly dysregulated and share features with two other inflammatory syndromes.
Published on in CHOP News
Alexis Anne Thompson, MD, to fulfill new leadership role, bringing with her expertise in blood disorders and clinical practice.
Published on in CHOP News
Results from multicenter study are first to show improved production of coagulation factor VIII over prolonged period, leading to reduction or complete elimination of bleeding events.
Published on in CHOP News
For patients fighting sickle cell disease, finding compassionate care is part of the battle. A CHOP hematologist discusses the importance of caring for patients beyond the hospital.